My site

Ambarella’s new 5 nm CV5 AI vision CVflow® processor sets a new standard for power efficiency with 8K video recording in under 2 watts

SANTA CLARA, Calif.-Monday 11 January 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Ambarella, Inc. (Nasdaq: AMBA), an AI vision silicon company, today unveiled CV5, an artificial intelligence (AI) vision processor capable of recording 8K video or four 4K video streams. The new system on chip (SoC) will enable the development of intelligent automotive camera systems, consumer cameras (drone, action, and 360°), and robotic cameras. It combines Ambarella’s powerful CVflow AI engine with dual Arm® A76 CPUs to provide the performance necessary for a wide range of AI-based algorithms. Its advanced image signal processor (ISP) can simultaneously process images for both human viewing and machine processing. Fabricated in advanced 5 nm process technology, CV5 consumes under 2 watts of power while encoding full 8K video ... Read more »

NEW YORK-Monday 11 January 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Following their announcement on 7 July 2020, Finsbury, The Glover Park Group (GPG) and Hering Schuppener have completed their merger and management buy-in of 49.99 per cent of the combined business. The merger will create a pre-eminent global strategic communications and public affairs consultancy, operating from 18 offices with almost 700 consultants. WPP will remain a 50.01 per cent investor and Mark Read, CEO of WPP, will join the Board.

Over the past six months, the three firms have worked to integrate their operations and today announce global executive leadership teams, who will be charged with overseeing operations and driving growth across their regions.

Alexander Geiser serves as Global CEO and Regional CEO for Europe, Mike Feldman and Winnie Lerner as Regional Co-CEOs for North America and Faeth Birch as Regional CEO for the United Kingdom, Middle East and Asia. As previously announce ... Read more »

High voltage GaN HEMTs for hi-rel applications now available in lower current 15 A and 30 A versions

MILPITAS, Calif.-Thursday 7 January 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Teledyne e2v HiRel is adding two new, ruggedized GaN power HEMTs (High Electron Mobility Transistors) to its industry-leading, 650-volt, high-power family of products based on GaN Systems technology.

The two new high-power HEMTs, TDG650E30B and TDG650E15B, deliver lower current performance of 30- and 15-amp respectively, while the original 650 V introduced last year, the TDG650E60, delivers 60 A.

These 650 V GaN HEMTs are the highest voltage GaN power devices available on the market for demanding high-reliability military, avionics, and space applications. They are an ideal fit for applications like power supply, motor control, and half bridge topologies.

They come with a bottom-side cooled configuration and feature ultra-low FOM Island Technology® die, low inductanc ... Read more »

LACHEN, Switzerland-Monday 11 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Octapharma announced today a satellite symposium and poster presentation at the 14th annual congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which will be held virtually from February 3–5, 2021.

The satellite symposium, A family journey with Nuwiq®: Early treatment decisions for long-term health, will be chaired by Dr Robert F. Sidonio Jr. (Hemophilia of Georgia Center for Bleeding and Clotting Disorders, Children’s Healthcare of Atlanta, Emory University, Atlanta, USA) and will follow the treatment journey of a family with two sons diagnosed with severe haemophilia A. Speakers will address key treatment decisions and considerations for long-term health, including prevention and treatment of bleeds, inhibitor risk, inhibitor eradication, and bone and joint health, in the context of the evolving haemophilia A treatment landscape. The symposium ... Read more »

 iFit ActivePulse allows a member’s heart rate to automatically adjust the treadmill’s speed and incline to always stay in the optimal heart rate zone

LOGAN, Utah -Monday 11 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- iFit, a global leader in interactive connected fitness technology, today announced the upcoming release of iFit ActivePulse automatic heart rate training. iFit’s cutting edge technology uses complex algorithms so an iFit subscriber’s heart rate controls the treadmill in real time, automatically adjusting the speed and incline to maintain the optimal heart rate zone.

iFit’s game-changing innovation removes the guesswork from heart rate training, by allowing a member’s heart rate to automatically scale and tailor iFit’s vast library of workouts to their individual fitness levels and goals. iFit has applied for patent protection on ActivePulse, which will be available on all iFit-contr ... Read more »

INGELHEIM, Germany & MOUNTAIN VIEW, Calif. -Monday 11 January 2021 [ AETOS Wire ]

● Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients

● Scientists from both companies will be breaking new ground in the application of quantum computing to molecular dynamics simulations

● Boehringer Ingelheim has set up a dedicated Quantum Lab with leading experts

(BUSINESS WIRE)-- Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations. The new partnership combines Boehringer Ingelheim’s leading expertise in the field of computer-aided drug design and in silico modeling with Google’s outstanding resources as one of the leading developers of qua ... Read more »

LAUSANNE, Switzerland-Monday 11 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today announced the appointment of Jorge Insuasty to the position of Chief Life Sciences Officer, effective Jan. 15, 2021. Mr. Insuasty will report to the company’s CEO, André Calantzopoulos.

“Jorge’s wealth of experience across both the pharmaceutical and consumer healthcare industries makes him the ideal candidate to succeed John O’Mullane, who is retiring,” said Calantzopoulos. “Jorge is a transformational leader in science and medicine and excels in driving product portfolio development through to market success. Science and a consumer-focused product portfolio are the cornerstones of our ambition to replace cigarettes with products that are a better choice than continued smoking. Jorge’s impressive track record will help ensure we reach our goals and take full advantage of adjacent revenue-gener ... Read more »